STOCKHOLDERS' EQUITY | 6 Months Ended |
Sep. 30, 2014 |
Stockholders' Equity Note [Abstract] | ' |
STOCKHOLDERS' EQUITY | ' |
NOTE 7 – STOCKHOLDERS' EQUITY |
|
Preferred Stock |
|
As of September 30, 2014, Lucas had 2,000 shares of Series A Convertible Preferred Stock issued and outstanding. Each share of the Series A Convertible Preferred Stock is convertible into 1,000 shares of the Company’s common stock and has no liquidation preference and no maturity date. Additionally, the conversion rate of the Series A Convertible Preferred Stock adjusts automatically in connection with and in proportion to any dividends payable by the Company in common stock. |
|
Common Stock |
|
The following summarizes Lucas's common stock activity during the six-month period ended September 30, 2014: |
|
| | | | | Common Shares | |
| | | | | Issued | | | | | | | |
| | Amount (a) | | | Per Share | | | Shares | | | Treasury | | | Outstanding | |
Balance at March 31, 2014 | | | | | | | | | 30,018,081 | | | | (36,900 | ) | | | 29,981,181 | |
Registered Direct Unit Offering | | $ | 1,802,090 | | | $ | 0.54 | | | | 3,333,332 | | | | - | | | | 3,333,332 | |
Restricted Stock Consideration | | | 47,250 | | | | 0.63 | | | | 75,000 | | | | - | | | | 75,000 | |
Share-Based Compensation | | | 17,992 | | | | 0.48 | | | | 37,171 | | | | - | | | | 37,171 | |
Balance at September 30, 2014 | | | | | | | | | | | 33,463,584 | | | | (36,900 | ) | | | 33,426,684 | |
|
| (a) | Net proceeds or fair market value on grant date, as applicable. | | | | | | | | | | | | | | | | | | |
|
On April 15, 2014, the Company agreed to sell an aggregate of 3,333,332 units to certain institutional investors at a purchase price of $0.60 per unit or $2 million in aggregate, with each unit consisting of one share of common stock (the “Shares”) and 0.50 of a warrant to purchase one share of the Company’s common stock at an exercise price of $1.00 per share and a term of five years (the “Warrants”, and collectively with the Shares, the “Units”). On April 21, 2014, the offering closed, and the Company subsequently received an aggregate of $2,000,000 in gross funding and a net of approximately $1.8 million (after deducting associated legal and placement agent fees). In total, the Company sold 3,333,332 shares of common stock and warrants to purchase 1,666,666 shares of common stock. The Company used the funds raised in the offering to pay expenses related to lease operating, workover activities and for general corporate purposes, including general and administrative expenses. |
|
On April 29, 2014, in connection with our entry into the Amended Letter Loan Agreement (see “Note 6. Notes Payable”), we agreed to issue 75,000 shares of restricted common stock at a purchase price of $0.63 per share (the closing sales price of the Company’s common stock on April 29, 2014), to Robertson Global Credit, LLC (“Robertson”), the administrator of the Loan, as additional consideration for the modifications. The listing of the shares was formally approved by the NYSE MKT LLC on May 8, 2014 and subsequently issued to Robertson on May 16, 2014. |
|
See Note 9 – Share-Based Compensation for information on common stock activity related to Share-Based Compensation, including shares granted to the board of directors, officers, employees and consultants. |
|
Warrants |
|
During the six months ended September 30, 2014, no warrants were exercised or cancelled. As discussed above, the Company granted warrants to purchase 1,666,666 shares with an exercise price of $1.00 per share and a term of five years in connection with the sale of units in the Company’s unit offering in April 2014. The warrants are treated as an equity instrument since the exercise price and shares are known and fixed at the date of issuance, and no other clause in the agreement requires the warrants to be treated as a liability. |
|
The following is a summary of the Company's outstanding warrants at September 30, 2014: |
|
Warrants | | | | Exercise | | Expiration | | Intrinsic Value at | | | | | | | | | | |
Outstanding | | | | Price ($) | | Date | | 30-Sep-14 | | | | | | | | | | |
2,510,506 | (1 | ) | | | 2.86 | | 4-Jul-16 | | $ | - | | | | | | | | | | |
1,032,500 | (2 | ) | | | 2.3 | | 18-Oct-17 | | | - | | | | | | | | | | |
275,000 | (3 | ) | | | 1.5 | | 4-Apr-18 | | | - | | | | | | | | | | |
50,000 | (4 | ) | | | 1.5 | | 31-May-18 | | | - | | | | | | | | | | |
279,851 | (5 | ) | | | 1.35 | | 13-Aug-18 | | | - | | | | | | | | | | |
1,666,666 | (6 | ) | | | 1 | | 21-Apr-19 | | | - | | | | | | | | | | |
5,814,523 | | | | | | | | | $ | - | | | | | | | | | | |
|
| -1 | Series B Warrants issued in connection with the sale of units in the Company’s unit offering in December 2010. The Series B Warrants became exercisable on July 4, 2011 and will remain exercisable thereafter until July 4, 2016. | | | | | | | | | | | | | | | | | | |
| -2 | Warrants issued in connection with the sale of units in the Company’s unit offering in April 2012. The warrants became exercisable on October 18, 2012, and will remain exercisable thereafter until October 18, 2017. | | | | | | | | | | | | | | | | | | |
| -3 | Warrants issued in connection with the issuance of the April 2013 Notes, for which the outstanding principal and interest was paid in full on August 16, 2013. The warrants were exercisable on the grant date (April 4, 2013) and remain exercisable until April 4, 2018. | | | | | | | | | | | | | | | | | | |
| -4 | Warrants issued in connection with the issuance of the May 2013 Notes, for which the outstanding principal and interest was paid in full on August 16, 2013. The warrants were exercisable on the grant date (May 31, 2013) and remain exercisable until May 31, 2018. | | | | | | | | | | | | | | | | | | |
| -5 | Warrants issued in connection with the Letter Loan. The warrants were exercisable on the grant date (August 13, 2013) and remain exercisable until the earlier of (a) August 13, 2018; and (b) three years after the payment in full of the Loan. | | | | | | | | | | | | | | | | | | |
| -6 | Warrants issued in connection with the sale of units in the Company’s unit offering in April 2014. The Warrants became exercisable on April 21, 2014 and will remain exercisable thereafter until April 21, 2019. | | | | | | | | | | | | | | | | | | |